Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Despite wide recognition of iRECIST, evidence regarding the impact of iRECIST over RECIST 1.1 is lacking. We aimed to evaluate the impact of iRECIST on assessing treatment efficacy of immune checkpoint inhibitors (ICIs) over RECIST 1.1. Articles that evaluated the treatment response and outcome base...

Full description

Bibliographic Details
Main Authors: Hyo Jung Park, Gun Ha Kim, Kyung Won Kim, Choong Wook Lee, Shinkyo Yoon, Young Kwang Chae, Sree Harsha Tirumani, Nikhil H. Ramaiya
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
RECIST
iRECIST
immunotherapy
checkpoint inhibitor
treatment efficacy
Online Access:https://www.mdpi.com/2072-6694/13/1/120

Internet

https://www.mdpi.com/2072-6694/13/1/120

Similar Items